Tudor Investment Corp
APGN

Tudor Investment Corp’s Apexigen, Inc. Common Stock APGN Stock Holding History

Tudor Investment Corp’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-89,746
Closed -$912K – 2826
2022
Q2 		$912K Sell
89,746
-12,254
-12% -$124K 0.02% 945
2022
Q1 		$1.03M Sell
102,000
-98,000
-49% -$983K 0.02% 906
2021
Q4 		$2M Hold
200,000
– – 0.03% 622
2021
Q3 		$1.99M Hold
200,000
– – 0.03% 706
2021
Q2 		$1.99M Hold
200,000
– – 0.04% 567
2021
Q1 		$1.97M Buy
+200,000
New +$2M 0.04% 529

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Tudor Investment Corp's APGN Position: Q3 2022 in Review

Tudor Investment Corp sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 89,746 shares — an estimated $912K sold.

Tudor Investment Corp first reported a position in APGN in Q1 2021 and held it in 6 quarters. The position peaked at $2M in Q4 2021. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Tudor Investment Corp reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 89,746 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $912K.
  • Tudor Investment Corp first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Tudor Investment Corp's Apexigen, Inc. Common Stock position peaked at $2M in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Tudor Investment Corp's 13F filing for Q3 2022, filed 14 Nov 2022.